Detalhe da pesquisa
1.
Immunogenicity and safety of an adjuvanted inactivated polio vaccine, IPV-Al, following vaccination in children at 2, 4, 6 and at 15-18 months.
Vaccine
; 38(21): 3780-3789, 2020 05 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32273184
2.
Immunogenicity and safety of an adjuvanted inactivated polio vaccine, IPV-Al, compared to standard IPV: A phase 3 observer-blinded, randomised, controlled trial in infants vaccinated at 6, 10, 14â¯weeks and 9â¯months of age.
Vaccine
; 38(3): 530-538, 2020 01 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-31703934
3.
Double-blind randomized Phase I study comparing rdESAT-6 to tuberculin as skin test reagent in the diagnosis of tuberculosis infection.
Tuberculosis (Edinb)
; 88(3): 249-61, 2008 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-18155963
4.
Immunogenicity and safety of three aluminium hydroxide adjuvanted vaccines with reduced doses of inactivated polio vaccine (IPV-Al) compared with standard IPV in young infants in the Dominican Republic: a phase 2, non-inferiority, observer-blinded, randomised, and controlled dose investigation trial.
Lancet Infect Dis
; 17(7): 745-753, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28454674
5.
First-in-human safety and immunogenicity investigations of three adjuvanted reduced dose inactivated poliovirus vaccines (IPV-Al SSI) compared to full dose IPV Vaccine SSI when given as a booster vaccination to adolescents with a history of IPV vaccination at 3, 5, 12months and 5years of age.
Vaccine
; 35(4): 596-604, 2017 01 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-28027810
6.
A novel liposomal adjuvant system, CAF01, promotes long-lived Mycobacterium tuberculosis-specific T-cell responses in human.
Vaccine
; 32(52): 7098-107, 2014 Dec 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-25454872
7.
Experience with monocomponent acellular pertussis combination vaccines for infants, children, adolescents and adults--a review of safety, immunogenicity, efficacy and effectiveness studies and 15 years of field experience.
Vaccine
; 31(45): 5178-91, 2013 Oct 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-23994021
8.
A randomised, double-blind, non-inferiority clinical trial on the safety and immunogenicity of a tetanus, diphtheria and monocomponent acellular pertussis (TdaP) vaccine in comparison to a tetanus and diphtheria (Td) vaccine when given as booster vaccinations to healthy adults.
Vaccine
; 30(37): 5464-71, 2012 Aug 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-22776216
9.
First-in-man open clinical trial of a combined rdESAT-6 and rCFP-10 tuberculosis specific skin test reagent.
PLoS One
; 5(6): e11277, 2010 Jun 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-20593018
10.
Risk of sensitization in healthy adults following repeated administration of rdESAT-6 skin test reagent by the Mantoux injection technique.
Tuberculosis (Edinb)
; 89(2): 158-62, 2009 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-19208500
11.
Transient facial nerve paralysis (Bell's palsy) following intranasal delivery of a genetically detoxified mutant of Escherichia coli heat labile toxin.
PLoS One
; 4(9): e6999, 2009 Sep 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-19756141
12.
Safety and immunogenicity of a DTaP-IPV(Vero) (serum-free) combination vaccine in comparison to DTaP-IPV(Mkc) when administered simultaneously with Haemophilus influenzae type B conjugate vaccine (PRP-T) in children at 2, 3.5, 5 and 16 months of age.
Vaccine
; 26(41): 5296-303, 2008 Sep 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-18675870
13.
Safety and immunogenicity of a booster dose of inactivated poliovirus vaccine produced in vero-cells.
Vaccine
; 22(8): 958-62, 2004 Feb 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-15161072
14.
Itching nodules and hypersensitivity to aluminium after the use of adsorbed vaccines from SSI.
Vaccine
; 22(15-16): 1845, 2004 May 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-15121293